Universal Health Realty Income Trust filed its third-quarter 2026 earnings press release on October 27, 2026, reporting net income of $4.9 million for the three-month period ended September 30, 2026.

Key Highlights

  • Q3 2026 net income: $4.9 million, or $.35 per diluted share, up from $4.0 million, or $.29 per diluted share, in Q3 2025.
  • Q3 2026 FFO: $12.3 million, or $.88 per diluted share, compared to $12.2 million, or $.88 per diluted share, in Q3 2025.
  • Nine-month net income: $15.9 million, or $1.14 per diluted share, for the period ended September 30, 2026, versus $13.3 million, or $.96 per diluted share, in the comparable 2025 period.
  • Nine-month FFO: $37.1 million, or $2.67 per diluted share, up from $35.9 million, or $2.59 per diluted share, in the comparable 2025 period.
  • Quarterly dividend: $.75 per share, or $10.4 million in aggregate, declared September 8, 2026 and paid September 30, 2026.
  • Credit facility: $97.3 million of available borrowing capacity as of September 30, 2026, with $377.7 million of outstanding borrowings under the $475 million credit agreement maturing September 30, 2028.
  • Chicago land sale: In October 2026, a parcel of land was sold for net cash proceeds of $1.96 million, with an expected gain of approximately $1.90 million to be recorded in Q4 2026.

Universal Health Realty Income Trust Q3 and Nine-Month 2026 Financial Results

According to the filing, Universal Health Realty Income Trust (NYSE:UHT) reported net income of $4.9 million, or $.35 per diluted share, for the three-month period ended September 30, 2026. The company attributed the $913,000 increase over Q3 2025 primarily to three factors: a net aggregate increase of $901,000 related to nonrecurring depreciation expense recorded in Q3 2025, an increase of $287,000 from lower interest expense due to a decrease in the average effective borrowing rate, and a decrease of $275,000 from a one-time settlement and release agreement executed in Q3 2025 in connection with one of its medical office buildings.

For the nine-month period ended September 30, 2026, the company disclosed net income of $15.9 million, or $1.14 per diluted share. The filing noted that results included a gain on the sale of land of $724,000, recorded in the second quarter of 2026, from the sale of a Chicago, Illinois parcel for net cash proceeds of $746,000. After adjusting for this gain, the company reported adjusted net income of $15.1 million, or $1.09 per diluted share. Nine-month FFO, which the filing states excludes depreciation, amortization, and gain on sale of land, reached $37.1 million, or $2.67 per diluted share, an increase of approximately $1.1 million from the comparable 2025 period.

The filing also disclosed progress on the Miller Medical Plaza, an 80,000 square foot medical office building in Palm Beach Gardens, Florida, for which construction commenced in February 2026 and is expected to be completed in December 2026. The estimated cost is approximately $34 million. A wholly-owned subsidiary of UHS has executed a 10-year master flex lease for approximately 75% of the rentable square feet. Additionally, in October 2026, the company sold one of its two remaining Chicago land parcels, representing approximately 42% of the remaining acreage, for net cash proceeds of $1.96 million. The filing states that the company is a real estate investment trust with investments or commitments in seventy-seven properties located in twenty-one states. Forward-looking statements in the release are the company's own and subject to its cautionary language.

What Was Disclosed

The filing reported Q3 2026 and nine-month 2026 financial results for Universal Health Realty Income Trust, including net income, FFO, dividend, credit facility status, Chicago land sales, and construction progress at Miller Medical Plaza.